Follow
Professor Srinivas Nanduri
Professor Srinivas Nanduri
NIPER Hyderabad
Verified email at gov.in
Title
Cited by
Cited by
Year
Anticancer and immunostimulatory compounds from Andrographis paniculata
RA Kumar, K Sridevi, NV Kumar, S Nanduri, S Rajagopal
Journal of ethnopharmacology 92 (2-3), 291-295, 2004
7912004
Synthesis and structure–activity relationships of andrographolide analogues as novel cytotoxic agents
S Nanduri, VK Nyavanandi, SSR Thunuguntla, S Kasu, MK Pallerla, ...
Bioorganic & medicinal chemistry letters 14 (18), 4711-4717, 2004
2682004
4 (3H)-Quinazolinone derivatives: Promising antibacterial drug leads
S Gatadi, TV Lakshmi, S Nanduri
European journal of medicinal chemistry 170, 157-172, 2019
1612019
DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells
C Satyanarayana, DS Deevi, R Rajagopalan, N Srinivas, S Rajagopal
BMC cancer 4, 1-8, 2004
1292004
Targeting AMPK in diabetes and diabetic complications: energy homeostasis, autophagy and mitochondrial health
YV Madhavi, N Gaikwad, VG Yerra, AK Kalvala, S Nanduri, A Kumar
Current medicinal chemistry 26 (27), 5207-5229, 2019
972019
Recent advances in Rh (III)/Ir (III)-catalyzed C–H functionalization/annulation via carbene migratory insertion
S Kumar, S Nunewar, S Oluguttula, S Nanduri, V Kanchupalli
Organic & Biomolecular Chemistry 19 (7), 1438-1458, 2021
952021
Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats
S Bathina, N Srinivas, UN Das
Biochemical and biophysical research communications 486 (2), 406-413, 2017
882017
Andrographolide: A natural product template for the generation of structurally and biologically diverse diterpenes
SGS Kandanur, N Tamang, NR Golakoti, S Nanduri
European Journal of Medicinal Chemistry 176, 513-533, 2019
692019
Rh(III)-Catalyzed Chemodivergent Annulations between Indoles and Iodonium Carbenes: A Rapid Access to Tricyclic and Tetracyclic N-Heterocylces
S Nunewar, S Kumar, H Pandhare, S Nanduri, V Kanchupalli
Organic Letters 23 (11), 4233-4238, 2021
672021
Co (III), Rh (III) & Ir (III)‐Catalyzed Direct C− H Alkylation/Alkenylation/Arylation with Carbene Precursors
S Nunewar, S Kumar, S Talakola, S Nanduri, V Kanchupalli
Chemistry–An Asian Journal 16 (5), 443-459, 2021
672021
Cinnamamide: An insight into the pharmacological advances and structure–activity relationships
N Gaikwad, S Nanduri, YV Madhavi
European Journal of Medicinal Chemistry 181, 111561, 2019
662019
Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and …
SJS Basha, SA Naveed, NK Tiwari, D Shashikumar, S Muzeeb, TR Kumar, ...
Journal of Chromatography B 853 (1-2), 88-96, 2007
632007
Synthesis of 1, 2, 3-triazole linked 4 (3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus
S Gatadi, J Gour, M Shukla, G Kaul, S Das, A Dasgupta, S Malasala, ...
European Journal of Medicinal Chemistry 157, 1056-1067, 2018
612018
Biological investigation and structure–activity relationship studies on azadirone from Azadirachta indica A. Juss
S Nanduri, SSR Thunuguntla, VK Nyavanandi, S Kasu, PM Kumar, ...
Bioorganic & medicinal chemistry letters 13 (22), 4111-4115, 2003
572003
Promising antibacterial agents against multidrug resistant Staphylococcus aureus
S Gatadi, YV Madhavi, S Chopra, S Nanduri
Bioorganic Chemistry 92, 103252, 2019
522019
Dithiocarbamate and CuO promoted one-pot synthesis of 2-(N-substituted)-aminobenzimidazoles and related heterocycles
P Das, CK Kumar, KN Kumar, MD Innus, J Iqbal, N Srinivas
Tetrahedron Letters 49 (6), 992-995, 2008
522008
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis
S Malasala, MN Ahmad, R Akunuri, M Shukla, G Kaul, A Dasgupta, ...
European Journal of Medicinal Chemistry 212, 112996, 2021
462021
FabI (enoyl acyl carrier protein reductase)-A potential broad spectrum therapeutic target and its inhibitors
P Rana, SM Ghouse, R Akunuri, YV Madhavi, S Chopra, S Nanduri
European journal of medicinal chemistry 208, 112757, 2020
462020
Protein kinase inhibitors
T Linnanen, G Wohlfahrt, S Nanduri, R Ujjinamatada, S Rajagopalan, ...
US Patent 9,447,091, 2016
462016
Novel routes for the generation of structurally diverse labdane diterpenes from andrographolide
S Nanduri, VK Nyavanandi, SSR Thunuguntla, M Velisoju, S Kasu, ...
Tetrahedron letters 45 (25), 4883-4886, 2004
462004
The system can't perform the operation now. Try again later.
Articles 1–20